Resources

Acclinate leverages its platforms to reach BIPOC communities with relevant content, resources, and experiences for Inflammatory Bowel Disease (IBD).

See how MMRF and NOWINCLUDED worked together to educate and empower the black community.

By using the “Affective Trust Framework” along with insights from the FDA, TA-specific resources, and a review of organizational gaps, sponsors can develop tailored playbooks to enhance clinical trial diversity.

The Bridging the Gap initiative by Acclinate aimed to empower underrepresented communities to use AI/ML to address health disparities.

This study highlights the benefits of a community-based pharmacy model to encourage REMP participation in clinical trials.

See how Acclinate accessed, engaged, and mobilized BIPOC women and birthing persons of childbearing age, a historically marginalized community, to participate in clinical trials.

Download this in-depth guide to gain a comprehensive understanding of clinical trial diversity challenges and solutions to drive health equity.

Lightship partnered with Acclinate to increase African American representation in a phase 3 clinical trial for Alzheimer’s disease.

In December 2015, the Vega family’s
world was rocked when they received
their two-year-old daughter Tiana’s
Rett Syndrome diagnosis.

Here are the 8 best practices for revolutionizing clinical trial diversity to make research more inclusive.

Our CEO Del Smith, PhD and Chief Medical Lead Camille Pope, PharmD, RPh led a discussion on increasing engagement and recruitment of communities of color in clinical trials.

Hear from leaders in technology, governance, investment, and community engagement about how they are improving health equity through increased diversity and representation in research.